Evidence map›Paper›PMID 28222395›Full record

ArticleBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2017

Technetium-99m radiolabeled paclitaxel as an imaging probe for breast cancer in vivo.

Liziane O F Monteiro, Renata S Fernandes, Luciano C Castro, Valbert N Cardoso, Mônica C Oliveira, Danyelle M Townsend, Alice Ferretti, Domenico Rubello, Elaine A Leite, André L B de Barros

Open access · greenAbstract read
In one paragraph

Article in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. [ACS omega · 2023
    Article
  2. Review
  3. Article
  4. Article
  5. Journal of drug delivery science and technology · 2020
    Article
  6. Article
  7. Restriction of drug transport by the tumor environment.Histochemistry and cell biology · 2018
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Liziane O F MonteiroDepartment of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Renata S FernandesDepartment of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Luciano C CastroDepartment of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Valbert N CardosoDepartment of Clinical and Toxicological Analyses, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Mônica C OliveiraDepartment of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Danyelle M TownsendDepartment of Drug Discovery and Pharmaceutical Sciences, Medical University of South Carolina, USA.
Alice FerrettiDepartment of Nuclear Medicine, Molecular Imaging, Radiology, Neuro Radiology, Medical Physics, Clinical Laboratory, Microbiology & Pathology, Santa Maria de la Misericordia Hospital, Rovigo, Italy.
Domenico RubelloDepartment of Nuclear Medicine, Molecular Imaging, Radiology, Neuro Radiology, Medical Physics, Clinical Laboratory, Microbiology & Pathology, Santa Maria de la Misericordia Hospital, Rovigo, Italy. Electronic address: Domenico.rubello@libero.it.
Elaine A LeiteDepartment of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
André L B de BarrosDepartment of Clinical and Toxicological Analyses, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. Electronic address: brancodebarros@yahoo.com.br.
Universidade Federal de Minas Gerais · BROspedale Santa Maria della Misericordia di Rovigo · ITMedical University of South Carolina · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20GM103542 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2012 to 2020
$20.2M
SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20RR024485 · NCRR · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2011 to 2011
$2.2M
NCI NIH HHS P30 CA138313NCRR NIH HHS P20 RR024485NIGMS NIH HHS P20 GM103542
6 · The paper itself

Abstract

The high incidence and mortality of breast cancer supports efforts to develop innovative imaging probes to effectively diagnose, evaluate the extent of the tumor, and predict the efficacy of tumor treatments while concurrently and selectively delivering anticancer agents to the cancer tissue. In the present study we described the preparation of technetium-99m (

Indexed as

AnimalsAntineoplastic Agents, PhytogenicBreast NeoplasmsFemaleHalf-LifeHumansIsotope LabelingMiceMice, Inbred BALB COrgan SpecificityPaclitaxelRadionuclide ImagingRadiopharmaceuticalsTechnetiumTissue DistributionAntineoplastic Agents, PhytogenicPaclitaxelRadiopharmaceuticalsTechnetium4T1 tumorBiodistribution profileBreast cancerPaclitaxelScintigraphic images

Identifiers

PMID28222395
PMCPMC5553547
OpenAlexW2600104229

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.